The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

Authors :: Andrea A. Garcia
J. F. Van Der Heijden
Pieter H. Reitsma
Joost C. M. Meijers
F. R. Rosendaal
Amsterdam Cardiovascular Sciences
Vascular Medicine
Amsterdam institute for Infection and Immunity
General Internal Medicine
Source :: Journal of Thrombosis and Haemostasis, Journal of thrombosis and haemostasis, 4(6), 1418-1420. Wiley-Blackwell, Journal of Thrombosis and Haemostasis, 4(6), 1418-1420. Blackwell Publishing
Publication Year :: 2006
Publisher :: Elsevier BV, 2006.

Subjects :: Factor VIII
Vitamin K
medicine.drug_class
Anticoagulants
Hemorrhage
Hematology
Vitamin K antagonist
Pharmacology
Biology
ABO Blood-Group System
Risk Factors
Case-Control Studies
ABO blood group system
von Willebrand Factor
Immunology
medicine
Humans
Warfarin

Tools